Health Care/Hospital
Number of Registered Users on Ping An Good Doctor Officially Exceeds 300 Million
SHANGHAI, Sept. 23, 2019 /PRNewswire/ -- The world's leading online healthcare ecosystem platform,Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor"; stock code: 01833.HK) announced on 23 September that the number of registered users onPing An Good Doctor exceeded 300 mil...
2019-09-23 14:27
10755
New Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care
Not intended for distribution in the USA, Canada or the UK Key ESMO Abstracts # BAVENCIO® (avelumab): 1451; 3152; 4174; 4256; 4823; 5113, ERBITUX® (cetuximab): 1212, 2589, 4455,Tepotinib (MET kinase inhibitor): 3930; 5373; 5455, M6620 (ATR inhibitor): 1547, Combinations: 4062; 4934. * N...
2019-09-23 14:00
2900
Digital Transformation Initiatives to Inject Fresh Impetus into Medtech Industry
Industry's shifting focus from selling products to providing complete patient care solutions will counter its slowdown, predicts Frost & Sullivan LONDON, Sept. 23, 2019 /PRNewswire/ -- The traditional medtech industry's growth rate is expected to drop gradually beyond 2020, from 5.8% to as low as...
2019-09-23 13:00
2215
Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells
World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer BOLOGNA, Italy and HUNTINGDON VALLEY, Pennsylvania, Sept. 23, 2019 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell tech...
2019-09-23 08:15
794
2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors
SUZHOU, China, Sept. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced results from the microsatellite instability high/deficient mismatch repair (MSI-H/dMMR) solid tumor cohort in the GEMSTONE-101 Phase Ib study of the Company's investigation...
2019-09-22 14:22
1910
2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab
SUZHOU, China, Sept. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced preliminary results from the Phase Ia trial of the Company's anti-CTLA-4 antibody in an oral presentation at the 22nd Annual Meeting of the Chinese Society of Clinical Onco...
2019-09-22 13:39
2072
Week's Top Stories
Most Reposted
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
[Picked up by 350 media titles]
2024-09-18 11:30
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
[Picked up by 315 media titles]
2024-09-16 11:50
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
[Picked up by 284 media titles]
2024-09-14 17:37
Illumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
[Picked up by 283 media titles]
2024-09-19 14:00
Watsons-Marlow unveils Qdos™ H-FLO and WMArchitectTM :Innovating fluid solutions for the chemical and biopharmaceutical industries respectively
[Picked up by 274 media titles]
2024-09-19 08:00
Most Read
Mox Capital Announces Strategic Support for Rapid-Scaling Startups Across Vietnam and Southeast Asia
2024-09-14 17:37
9912
Maiji Mountain Grottoes: Carved in stone, evolving in time
2024-09-14 13:23
8347
FETC International's MD Dr. Y.C. Chang Honored with the "Master Entrepreneur Award" at APEA 2024
2024-09-16 11:50
8265
Vision China: US, China urged to find right path in ties
2024-09-14 01:10
7843
Agoda and TPB Philippines join hands to bring the world to the Philippines' shores
2024-09-18 11:30
6827